{
  "id": "621145c63a8413c65300000c",
  "type": "factoid",
  "question": "When did FDA approve the first B-cell maturation antigen-targeted CAR-T cell therapy?",
  "ideal_answer": "FDA approved the first B-cell maturation antigen-targeted CAR-T cell therapy on March 26, 2021.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34549909",
    "http://www.ncbi.nlm.nih.gov/pubmed/32683672"
  ],
  "snippets": [
    {
      "text": "The most recent US Food and Drug Administration approval of the first B-cell maturation antigen-targeted CAR-T cell therapy on March 26, 2021, has paved a path forward for the eventual evaluation of more of these investigational agents undergoing clinical trials.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34549909",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "26 March 2021"
}